Statistics
Publications
24
Citations
5.8K
H-Index
17
Active since
2009
Dmitry Nosov is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, kidney cancer, and renal cell carcinoma.
Publications per year
2009–2025
24
24
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +9
Thomas Powles, Elizabeth R. Plimack, Denis Soulières et al. · The Lancet Oncology · 2020 · 745 citations
Medicine, Oncology, Pharmacology +13
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
Toni K. Choueiri, Thomas Powles, Katriina Peltola et al. · New England Journal of Medicine · 2024 · 142 citations
Medicine, Oncology, Pharmacology +17
1–5 of 24